SHL.DE after hours: Siemens Healthineers at €42.42 ahead of Feb 5 earnings

After hours, SHL.DE stock trades at €42.42 as investors position ahead of Siemens Healthineers’ earnings on 05 Feb 2026. Markets are watching margins, Varian integration updates, and diagnostics demand. We focus on valuation, cash flow metrics, and near-term catalysts that could move the XETRA-listed Siemens Healthineers AG (Germany) shares before the report.

Earnings calendar and expectations for SHL.DE stock

Siemens Healthineers reports on 2026-02-05 with consensus attention on EPS and guidance. The company shows EPS €1.91 and PE 22.08, setting a baseline for beats or misses. Analysts expect commentary on Diagnostics and Varian revenue mix to drive post-release moves.

Key financials and valuation snapshot

At €42.42, market cap stands near €47.30B with trailing PE at 22.08 and price-to-sales 2.02. Free cash flow yield is 4.79% and dividend yield is 2.25%, while return on equity is 11.56%. These metrics frame valuation versus the Healthcare sector average PE around 28–34.

Operational drivers, risks, and sector context

Imaging and Diagnostics drive revenue per share €20.93, with R&D at roughly 8.38% of sales. Risks include net debt to EBITDA near 2.81x and elongated receivables days at 113.44. The Healthcare sector in Germany has muted one-year performance, so SHL.DE’s growth and Varian synergy execution matter most.

Technicals and market activity on XETRA

Volume today is 313,489 versus average 936,843, with RSI 69.29 and Bollinger lower band €42.80. Short-term trend shows overbought indicators and a tight trading range €42.02–€42.49 after hours. Traders should watch volatility around the earnings release.

Meyka grade and model forecast for Siemens Healthineers

Meyka AI rates SHL.DE with a score of 69.34 out of 100 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of €47.33, implying 11.58% upside from €42.42. Forecasts are model-based projections and not guarantees.

Final Thoughts

Key takeaways for SHL.DE stock: the share trades at €42.42 after hours with EPS at €1.91 and PE 22.08, leaving modest valuation room versus sector peers. Short-term catalysts include the Feb 5 earnings print and Varian integration commentary. Meyka AI’s model shows a yearly target €47.33 (implied upside 11.58%) and a near-term monthly level around €44.30 (implied upside 4.43%). Balance the firm’s decent free cash flow yield 4.79% and dividend 2.25% against net debt leverage net debt/EBITDA 2.81x and long receivables. For XETRA traders in Germany, expect higher intraday volatility on release; analysts will weigh margin trends and order backlog. Remember, Meyka AI is an AI-powered market analysis platform and forecasts are not guarantees. Use earnings as a decision point and align position size with risk tolerance.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.